Rita Seeböck

Publikationen

Publikationen pro Jahr 2009 2017 2024

• 13 Artikel
• 4 Übersichtsartikel
• 3 Kapitel

Publikationen pro Jahr

Publikationen pro Jahr

Suchergebnisse

• 2024

  Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants

  Schatz, C., Knabl, L., Lee, H. K., Seeboeck, R., von Laer, D., Lafon, E., Borena, W., Mangge, H., Prüller, F., Qerimi, A., Wilflingseder, D., Posch, W. & Haybaeck, J., 15 Apr. 2024, in: Microorganisms. 12, 4, 798.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

  • SARS Coronavirus 100%
  • Eukaryotic Translation 25%
  • Protein Biosynthesis 25%
• 2022

  The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis

  Roblek, M., Bicher, J., van Gogh, M., György, A., Seeböck, R., Szulc, B., Damme, M., Olczak, M., Borsig, L. & Siekhaus, D. E., 8 Feb. 2022, in: Frontiers in Oncology. 12, S. 777634 777634.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

  • Major Facilitator Superfamily 100%
  • Integrin 100%
  • Synapsin I 100%
  • Cell Migration 12%
  • Surface Property 12%

• The Translational Bridge between Inflammation and Hepatocarcinogenesis

  Gufler, S., Seeboeck, R., Schatz, C. & Haybaeck, J., 3 Feb. 2022, in: Cells. 11, 3, 533.

  Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

  Open Access

  • Liver Carcinogenesis 100%
  • Initiation Factor 66%
  • Immunological Tolerance 50%
  • Intrinsic Factor 50%
  • Nonalcoholic Fatty Liver 33%
• 2020

  Promoter methylation of selected genes in non-small-cell lung cancer patients and cell lines

  Sarne, V., Huter, S., Braunmueller, S., Rakob, L., Jacobi, N., Kitzwögerer, M., Wiesner, C., Obrist, P. & Seeboeck, R., 28 Juni 2020, in: International Journal of Molecular Sciences. 21, 13, S. 1-22 22 S., 4595.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

  • Bisulfite 100%
  • DNA Methyltransferase 100%
• 2019

  Current coverage of the mTOR pathway by next-generation sequencing oncology panels

  Seeboeck, R., Sarne, V. & Haybaeck, J., 5 Feb. 2019, in: International Journal of Molecular Sciences. 20, 3, 690.

  Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

  Open Access

  • Next Generation Sequencing 100%
  • Mammalian Target of Rapamycin 100%
  • Diagnosis 50%
  • Awareness 25%
  • Somatic Mutation 25%

• The relevance of gender in tumor-influencing epigenetic traits

  Sarne, V., Braunmueller, S., Rakob, L. & Seeboeck, R., 28 Jän. 2019, in: Epigenomes. 3, 1, 6.

  Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

  Open Access

  • Environmental Influence 100%
  • DNA Methylation 100%
  • Epigenetic Modification 100%
  • Molecular Diagnostics 100%
  • Histone 100%
• 2018

  Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome

  Unterluggauer, J. J., Prochazka, K., Tomazic, P. V., Huber, H. J., Seeboeck, R., Fechter, K., Steinbauer, E., Gruber, V., Feichtinger, J., Pichler, M., Weniger, M. A., Consortium, G., Sill, H., Schicho, R., Neumeister, P., Beham-Schmid, C., Deutsch, A. J. A. & Haybaeck, J., 22 Aug. 2018, in: Blood Cancer Journal. 8, 9, S. 79 79.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

• Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection

  Zopf, A., Raim, R., Danzer, M., Niklas, N., Spilka, R., Pröll, J., Gabriel, C., Nechansky, A. & Roucka, M., 3 Apr. 2018, in: BioTechniques. 58, 3, S. 126-134 9 S.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access
• 2017

  ErbB family signalling: A paradigm for oncogene addiction and personalized oncology

  Jacobi, N., Seeboeck, R., Hofmann, E. & Eger, A., 12 Apr. 2017, in: Cancers. 9, 4, 33.

  Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

  Open Access

  • Oncogene 100%
  • ErbB 100%
  • Oncogene Addiction 100%
  • Drug Efficacy 33%
  • Signal Transduction 16%

• Molecular aspects of thyroid carcinogenesis

  Seeböck, R., Haybaeck, J. & Tsybrovskyy, O., 1 Juni 2017, Mechanisms of Molecular Carcinogenesis. Springer International Publishing AG, Band 1. S. 175-184 10 S.

  Publikation: Beitrag in Buch/Bericht/Konferenzband › Kapitel › Begutachtung

  • Epigenetics 100%
  • Protein Biosynthesis 100%
  • Energy Metabolism 100%
  • Hormone Sensitivity 100%
  • Carcinogenesis 100%

• Molecular carcinogenesis of urinary bladder cancer

  Seeböck, R. & Haybaeck, J., 22 Mai 2017, Mechanisms of Molecular Carcinogenesis. Springer International Publishing AG, Band 2. S. 191-205 15 S.

  Publikation: Beitrag in Buch/Bericht/Konferenzband › Kapitel › Begutachtung

  • Carcinogenesis 100%
  • Bladder Cancer 100%
  • Neoplasm 28%
  • Gene Expression Profiling 14%
  • Research Design 14%

• Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: Lessons learned from the inhibition of EGFR signaling

  Jacobi, N., Seeboeck, R., Hofmann, E., Schweiger, H., Smolinska, V., Mohr, T., Boyer, A., Sommergruber, W., Lechner, P., Pichler-Huebschmann, C., Onder, K., Hundsberger, H., Wiesner, C. & Eger, A., 8 Dez. 2017, in: Oncotarget. 8, 64, S. 107423-107440 18 S.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

  • Epidermal Growth Factor Receptor 100%
  • Cancer Cell Culture 100%
  • Kinase 25%
  • Phosphotransferase 25%
  • Cell Communication 25%

• Translational control and mTOR in cancer

  Seeböck, R., Golob-Schwarzl, N. & Krassnig, S., 1 Juni 2017, Mechanisms of Molecular Carcinogenesis. Springer International Publishing AG, Band 1. S. 77-86 10 S.

  Publikation: Beitrag in Buch/Bericht/Konferenzband › Kapitel › Begutachtung

  • Malignant Neoplasm 100%
  • Mechanistic Target of Rapamycin 100%
  • Mammalian Target of Rapamycin 100%
  • Neoplasm 33%
  • Biological Marker 16%
• 2016

  The combinatorial approach of lasercaptured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer

  Hofmann, E., Seeboeck, R., Jacobi, N., Obrist, P., Huter, S., Klein, C., Önder, K., Wiesner, C., Hundsberger, H. & Eger, A., 7 Apr. 2016, in: Biomarker Research. 4, 1, S. 8 8.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

  • Quantitative Reverse Transcription Polymerase Chain Reaction 100%
  • Breast Cancer 100%
  • Fluorescence in Situ Hybridization 50%
  • Immunohistochemistry 50%
  • Neoplasm 33%
• 2014

  eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation

  Spilka, R., Ernst, C., Bergler, H., Rainer, J., Flechsig, S., Vogetseder, A., Lederer, E., Benesch, M., Brunner, A., Geley, S., Eger, A., Bachmann, F., Doppler, W., Obrist, P. & Haybaeck, J., 29 Juli 2014, in: Cellular Oncology. 37, 4, S. 253-267 15 S.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  • Translation Initiation 100%
  • Initiation Factor 33%
  • Survival Rate 33%
  • Overall Survival 33%

• High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer

  Tymoszuk, P., Charoentong, P., Hackl, H., Spilka, R., Müller-Holzner, E., Trajanoski, Z., Obrist, P., Revillion, F., Peyrat, J.-P., Fiegl, H. & Doppler, W., 12 Apr. 2014, in: BMC Cancer. 14, 1, S. 257 257.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access

  • STAT1 100%
  • interferon 4%
• 2013

  Eukaryotic translation initiation factors in cancer development and progression

  Spilka, R., Ernst, C., Mehta, A. K. & Haybaeck, J., 28 Okt. 2013, in: Cancer Letters. 340, 1, S. 9-21 13 S.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

• The muscle dystrophy-causing ΔK32 lamin A/C mutant does not impair the functions of the nucleoplasmic lamin-A/C–LAP2α complex in mice

  Pilat, U., Dechat, T., Bertrand, A. T., Woisetschläger, N., Gotic, I., Spilka, R., Biadasiewicz, K., Bonne, G. & Foisner, R., 15 Apr. 2013, in: Journal of Cell Science. 126, 8, S. 1753-1762 10 S.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access
• 2012

  Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response

  Spilka, R., Laimer, K., Bachmann, F., Spizzo, G., Vogetseder, A., Wieser, M., Müller, H., Haybaeck, J. & Obrist, P., 23 Apr. 2012, in: Journal of Oncology. 2012, S. 901956 901956.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

  Open Access
• 2009

  Loss of LAP2α Delays Satellite Cell Differentiation and Affects Postnatal Fiber-Type Determination

  Gotic, I., Schmidt, W. M., Biadasiewicz, K., Leschnik, M., Spilka, R., Braun, J., Stewart, C. L. & Foisner, R., 28 Dez. 2009, in: Stem Cells. 28, 3, S. 480-488 9 S.

  Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung